AG
COLL icon

Aperio Group’s Collegium Pharmaceutical COLL Stock Holding History

Aperio Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,497
Closed -$219K – 2433
2020
Q3 		$219K Buy
10,497
+414
+4% +$7.47K ﹤0.01% 2196
2020
Q2 		$176K Buy
+10,083
New +$197K ﹤0.01% 2197
2019
Q3 		– Sell
-1,757
Closed -$23K – 2406
2019
Q2 		$23K Buy
+1,757
New +$23.5K ﹤0.01% 2673

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aperio Group's COLL Position: Q4 2020 in Review

Aperio Group sold out of Collegium Pharmaceutical (COLL) in Q4 2020, closing a stake of 10,497 shares — an estimated $219K sold.

Aperio Group first reported a position in COLL in Q2 2019 and held it in 3 quarters. The position peaked at $219K in Q3 2020. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2020.

  • Aperio Group reported no remaining Collegium Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 10,497 Collegium Pharmaceutical shares in Q4 2020, an estimated $219K.
  • Aperio Group first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 3 quarters.
  • Aperio Group's Collegium Pharmaceutical position peaked at $219K in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.